Harbor Investment Advisory’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-999
| Closed | -$54K | – | 1373 |
|
|
2022
Q3 | $54K | Hold |
999
| – | – | 0.01% | 661 |
|
|
2022
Q2 | $56K | Hold |
999
| – | – | 0.01% | 677 |
|
|
2022
Q1 | $70K | Buy |
999
+154
| +18% | +$10.8K | 0.01% | 642 |
|
|
2021
Q4 | $81K | Hold |
845
| – | – | 0.01% | 593 |
|
|
2021
Q3 | $73K | Hold |
845
| – | – | 0.01% | 607 |
|
|
2021
Q2 | $69K | Hold |
845
| – | – | 0.01% | 611 |
|
|
2021
Q1 | $80K | Sell |
845
-165
| -16% | -$15.6K | 0.01% | 540 |
|
|
2020
Q4 | $63K | Buy |
1,010
+271
| +37% | +$16.9K | 0.01% | 574 |
|
|
2020
Q3 | $44K | Buy |
739
+390
| +112% | +$23.2K | 0.01% | 523 |
|
|
2020
Q2 | $24K | Buy |
349
+41
| +13% | +$2.82K | 0.01% | 586 |
|
|
2020
Q1 | $14K | Buy |
+308
| New | +$14K | ﹤0.01% | 656 |
|